The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Faster detection of dangerous infections

Porträtt: Johan Malmström, Erik Hartman, Artur Schmidtchen
Johan Malmström, Erik Hartman and Artur Schmidtchen have developed a new innovative technique for peptide analysis that identifies new and better biomarkers for safer diagnostics in inflammation and infection. Foto Åsa Hansdotter

In an infection, there are tens of thousands of peptides that provide a wealth of information about which bacteria have caused the infection and how severe it is. A research team at Lund University has now combined clinical questions with mathematical methods to systematically analyze these peptides. This scientific breakthrough has the potential to transform the diagnosis and treatment of infections in the future.

Peptides are small fragments of proteins, mainly found in the skin and mucous membranes. Some peptides act as a barrier, protecting the body against infections by fighting off microorganisms like bacteria, viruses, and other pathogens, while others participate in the regulation of inflammation. When we have a wound or undergo surgery, this balance can sometimes be disrupted, allowing microorganisms to penetrate and cause acute infection and, in the worst cases, sepsis.
 
–  To diagnose infections today, the doctor first makes a clinical assessment and then sends a culture sample for further analysis. It usually takes a couple of days to get results on which bacteria are present in the wound, and this does not always provide a clear picture of the severity of the infection, says Artur Schmidtchen, Professor of Dermatology and Venereology at Lund University, and consultant at Skåne University Hospital.

The cool thing is that the algorithm is not limited to wound infections; it is general and can be applied to many different diseases where protein degradation plays a significant role

In an infected wound, there is a battle between the immune system and bacteria. Bacteria break down proteins into peptides as a strategy to acquire nutrients and spread, while the body uses similar strategies to fight bacteria and regulate inflammation. This interaction is incredibly complex, influenced by the types of bacteria present as well as the severity of the infection. The research team aimed to understand the degradation patterns of proteins to more quickly identify the bacteria involved and assess the risk of sepsis. The rise of antibiotic resistance has also increased the demand for alternative ways to diagnose and combat infections.
 
–  To investigate the number and types of peptides in a wound, we 'squeezed' peptides out of wound dressings and then analyzed them using mass spectrometry. This allowed us to identify up to 45 000 different peptides from a single infected wound, says Johan Malmström, Professor of Mass Spectrometry at Lund University.
 
This enormous amount of information is difficult to grasp and utilize for understanding the degradation patterns of proteins. It was not until Erik Hartman, an engineer and PhD student at Lund University, developed an algorithm that reduces the compilation of peptides by 95 percent, down to just a few hundred peptide clusters, that the data could be analyzed and used. By clustering the peptides, he was able to train machine learning models to determine the quantities and types of bacteria present in the wound. After identifying unique peptide patterns and changes in these patterns based on different types of bacteria, the researchers can now assess the severity of the infection.
 
–  We have mapped how protein degradation patterns vary in different types of wound infections, gaining better insight into how they differ by systematically analyzing the peptide clusters. This allows us to easily identify subgroups that can guide treatments, says Erik Hartman.
 
These unique biomarkers can lead to earlier and more accurate diagnoses, enabling the faster detection and treatment of potential infections. With mass spectrometry and machine learning, the entire process takes only a few minutes.
 
–  The cool thing is that the algorithm is not limited to wound infections; it is general and can be applied to many different diseases where protein degradation plays a significant role. Peptides thus become a new source of information that can, in the next step, help tailor treatments and contribute to finding new drug candidates, says Erik Hartman.
 
The next step for the researchers is to conduct larger studies to further validate the results, refine the methodology and analyze other types of diseases, such as sepsis. They also want to explore how the method can be applied clinically in real diagnostic situations to assess its practical usefulness.

 

Publication

"Peptide clustering enhances large-scale analyses and reveals proteolytic signatures in mass spectrometry data"
Nature Communications, August 2024.

The study has been funded with support from: the Swedish Research Council, the Edvard Welander Foundation, the Finsen Foundation, the Royal Physiographic Society in Lund, the Crafoord Foundation, the Alfred Österlund Foundation, and ALF funds.

Quick Facts: Peptides and Mass Spectrometry

Peptides are short sequences of amino acids—fragments of proteins. They are versatile and can have various functions and properties depending on their structure. They play a crucial role in many biological processes, from immune system defense to hormone regulation and nerve signaling.

Mass Spectrometry is an analytical method used to identify and quantify substances in a sample, such as proteins or chemical compounds. The technique separates molecules based on their mass-to-charge ratio, allowing the identification of thousands of molecules in, for example, wound fluid and blood plasma.

Contact

Erik Hartman, Engineer and PhD student in Infectious Medicine at Lund University.
Profile in Research Portal

Johan Malmström, Professor of Mass Spectrometry at Lund University.
Profile in Research Portal
 
Artur Schmidtchen, 
Professor of Dermatology and Venereology at Lund University, and Senior Consultant at Skåne University Hospital.
Profile in Research Portal